Exec Chat: Abbott Bets On Modular And Leadless Devices To Be The Future Of Cardiac Rhythm Management

10 Aug 2022

Medtech Insight interviewed Leonard Ganz, a veteran cardiac electrophysiologist who recently joined Abbott’s cardiac rhythm management business as its divisional vice president of medical affairs and chief medical officer.

Abbott's Aveir VR leadless pacemaker • Source: Abbott

The cardiac rhythm management technology industry is shifting from implantable devices with difficult-to-explant transvenous leads to leadless devices integrated into modular systems.

Abbott is competing with Medtronic and Boston Scientific to lead this change. The US Food and Drug...